A three-year study of a first-generation chemotherapy-compounding robot.

Purpose: Results of a performance evaluation of an automated system for compounding antineoplastic preparations are reported.

Methods: Three years after the pharmacy department of a hospital in Saudi Arabia installed an i.v.